Vishal Gulati

Vishal Gulati has diverse work experience in the healthcare and investment sectors. Vishal is the Founder and Managing Partner of Transatalantic Healthtech Fund since 2022. Prior to this, Vishal worked as a Venture Capitalist specializing in healthtech investments since 2012. Vishal also served as the Chairman of the Seed Fund Investment Committee at Cancer Research UK (CRUK) and as a Member of the Board of Advisors at Reuben College, University of Oxford. Vishal has been an advisor and investor for various companies including ZOE, Fluidic Analytics, Turbine.AI, Kheiron Medical, Endomag, and Closed Loop Medicine.

Vishal Gulati has a diverse educational background in the field of medicine. Vishal started their education in 1994 at the University of Oxford, where they pursued a study program related to the UNESCO Fellowship. In 1995, they also joined Imperial College London as a Clinical Research Fellow, specializing in Postgraduate Medicine in the field of Clinical Medicine. Additionally, Vishal Gulati received a Rhodes Scholarship in 1995, focusing on Medicine. Aside from their educational qualifications, they also hold a certification as one of the "100 Most Influential Health Tech Leaders 2016" from Hot Topics institution.